Abstract The dihydropyridine receptor (DHPR) in the skeletal muscle plasma membrane functions as a voltage sensor for excitation-contraction coupling. In the present work the expression and special features of DHPR were studied under various conditions. In order to localize and visualize the DHPRs, a method using fluorophore-conjugated dihydropyridine molecules as a probe was developed. In addition, different laboratory assays and electrophysiological measurements were used to study the expression of the myofibrillar proteins, force production of the muscle and conduction velocity of the plasma membrane. During the postnatal development of mouse skeletal muscle the density of DHPR increased. By the time of DHPR appearance, the expression of sodium channels had started and the typical assembly of basic structural components and membrane compartments was clearly detectable. According to the histochemical analysis, the DHPR was selectively expressed in type IIA muscle fibres of mouse. In addition to the fibre type specificity, the uneven distribution of DHPRs was also seen at the muscle level. The attenuation of the contraction force after addition of DHPR blocker was largest in muscles with a high percentage of type IIA fibres. In fish muscles, the distribution of DHPR was homogenous and the density between different fibre types was quite similar. In gastrocnemius muscle of mouse, the density and mRNA expression of DHPR increased significantly by 21.5 and 66.8%, respectively, after a 15-week aerobic exercise programme. The increase correlated significantly with the raise in % myosin heavy chain IIa isoform. In thigh and heart muscles, no significant changes were observed. In fish, the environmental change following hatchery release and downstream migration of 46.5 km induced an increase in the DHPR density in swimming muscles. Furthermore, a transition of phenotypic profile from fast-to-slow fibres was observed. Taken together, the present data provide evidence for the fact that the expression of DHPR increases during postnatal development. Moreover, the expression correlates with a specific fibre-type metabolism, thus having an impact on the overall contractile properties of the muscle. This is further manifested as an increase in the DHPR density after endurance training in mammalian as well as in fish muscle. In addition, a strong correlation exists between the level of muscle activity and the density of DHPR. / Tiivistelmä Poikkijuovaisen lihaksen solukalvolla esiintyvä dihydropyridiini (DHP) reseptori toimii jännitesensorina lihaksen ärsytys-supistus kytkennässä. Tässä työssä tutkittiin DHP reseptorin erityispiirteitä sekä erilaisten fysiologisten tekijöiden vaikutusta reseptorin ilmenemiseen. DHP reseptorien visualisointiin kehitettiin histologinen värjäysmenetelmä, jossa merkkiaineena toimi fluorofori-konjugoitu DHP molekyyli. Lisäksi työssä tutkittiin lihaksen proteiinien ekspressiota, lihaksen voimantuottoa sekä solukalvon johtonopeutta erilaisten määritysmenetelmien ja elektrofysiologisten mittausmenetelmien avulla. Tulokset osoittivat, että yksilönkehityksen aikana DHP reseptorien tiheys kasvoi hiiren poikkijuovaisessa lihaksessa. DHP reseptorien ekspression alkaessa natriumkanavat olivat jo ilmaantuneet solukalvolle ja lihassolun rakenne oli pitkälle erilaistunut. Histokemiallisten määritysten perusteella DHP reseptorin ekspressio oli selektiivistä. Reseptoreita esiintyi runsaimmin tyypin IIA soluissa. Reseptoriproteiinin solutyyppispesifisyys oli huomattavissa myös lihastasolla. Tulosten mukaan proteiinin salpaaja alensi lihaksen supistumisvoimaa erityisesti niissä hiiren lihaksissa, joiden solutyyppikoostumuksessa tyypillä IIA on suuri prosentuaalinen osuus. Kalan lihaksissa DHP reseptorit olivat homogeenisesti jakautuneet. Lisäksi reseptoritiheys oli samankaltainen eri solutyyppien välillä. 15 viikon aerobinen harjoittelu lisäsi sekä DHP reseptorin proteiini- että mRNA- ekspressiota tilastollisesti merkitsevästi (21,5 ja 66,8 %) hiiren kantalihaksessa. Ekspression kasvu korreloi merkitsevästi samanaikaisesti tapahtuneen myosiini isomuoto IIa määrän kasvun kanssa. Reisi- ja sydänlihaksessa merkittäviä muutoksia ei havaittu. Kalan uintilihaksissa DHP reseptorien tiheys kasvoi vapauttamisen jälkeisen ympäristön muutoksen ja 46,5 km pituisen vaelluksen jälkeen. Lisäksi lihasten solutyyppikoostumuksessa tapahtui muutos kohti hitaasti supistuvia solutyyppejä. Yhteenvetona voidaan todeta, että saatujen tulosten perusteella DHP reseptorien ekspressio kasvaa syntymän jälkeen hiiren poikkijuovaisessa lihaksessa. Solujen erilaistuessa ekspressio korreloi solutyyppimetabolian kanssa vaikuttaen edelleen lihaksen supistumisominaisuuksiin. Tästä johtuen myös kestävyysharjoittelun seurauksena DHP reseptorien määrä kasvaa sekä nisäkkään että kalan lihaksissa. Erityisesti lihaksen aktiivisuudella on merkitystä DHP reseptorin ekspressioon.

O exercício resistido dinâmico é recomendado para hipertensos, mas a pressão arterial (PA) se eleva muito durante sua execução. Este estudo investigou o efeito do antagonista do canal de cálcio diidropiridínico, anlodipina, sobre a resposta da PA ao exercício resistido de diferentes intensidades. Onze hipertensos essenciais foram estudados após 4 semanas de uso de placebo e anlodipina, num desenho aleatório e duplo cego. Os voluntários realizaram o exercício de extensão de joelhos até a exaustão, seguindo os seguintes protocolos: a) 1 série em 100% de 1RM, b) 3 séries em 80% de 1RM; e c) 3 séries em 40% de 1RM. Antes e durante os exercícios, a PA foi medida diretamente na artéria radial. A anlodipina reduziu os valores absolutos da PA sistólica (225±6 vs 207±6 mmHg em 100%, 289±8 vs 273±10 mmHg em 80% e 289±10 vs 271±11 mmHg em 40%) e da PA diastólica (141± 3 vs 130±6 mmHg em 100%, 178±5 vs 169±6 mmHg em 80% e 176±8 vs 154±6 mmHg em 40%) em todas as intensidades. Ela também minimizou o aumento da PA diastólica que ocorreu na 2ª e 3ª séries do exercício realizado em 40% de 1 RM. Em conclusão, anlodipina é capaz de diminuir os valores máximos da PA atingidos durante a realização de exercícios resistidos de diferentes intensidades e minimizar o aumento progressivo da PA diastólica em exercícios mais prolongados.Estes efeitos podem reduzir o risco cardiovascular durante a execução de esforços resistidos em hipertensos / Dynamic resistance exercise is recommended for hypertensives. However, during its execution blood pressure (BP) presents a huge increase. This study investigated the effects of dyhidropyridine calcium channel antagonist, amlodipine, on BP responses during resistance exercises executed at different intensities. Eleven essential hypertensives were studied after 4 weeks of placebo and amlodipine administered at a random double blinded order. Volunteers were evaluated during the execution of the knee extension exercise performed with three different protocols: a) 1 set at 100% of 1RM (repetition maximum), b) 3 sets at 80% of 1RM, and c) 3 sets at 40% of 1RM. Before and during exercise, BP was directly measured at the radial artery. Amlodipine reduced the absolute values of systolic BP (225±6 vs 207±6 mmHg at 100%, 289±8 vs 273±10 mmHg at 80% e 289±10 vs 271±11 mmHg at 40%) and diastolic BP (141± 3 vs 130±6 mmHg at 100%, 178±5 vs 169±6 mmHg at 80% e 176±8 vs 154±6 mmHg at 40%) during all the exercise intensities. In addition, it mitigated diastolic BP increase that happened at the second and third sets of the exercise at 40% of 1 RM. In conclusion, amlodipine was able to decrease BP maximal values achieved during resistance exercise at different intensities, and minimizes diastolic BP increase in prolonged resistance exercises. These effects may confer some cardiovascular protection for hypertensives during the execution of resistance efforts

<p>Dendritic spines are mushroom-shaped appendages on the dendritic branches of neurons. They are invaluable to the function of the brain as they form the major site for excitatory signal transmission in the mammalian brain. These ubiquitous structures have several invaluable and unique characteristics – namely that their morphological and functional characteristics are activity-dependent and undergo remodeling as the spine experiences stimulation. This activity-dependent regulation then in turn modulates the excitatory postsynaptic potential that propagates into the adjacent parent dendrite, and which ultimately reaches the somatic compartment. The mediation of this modulatory effect on the postsynaptic signal by dendritic spines renders them invaluable to the brain’s ability to change neuronal circuits as it learns. The relationship between the structural and functional change in dendritic spines as plasticity is induced remains poorly understood; while efforts have been made to examine the morphology of dendritic spines during plasticity as well as the change to receptor insertion on the postsynaptic density, a comprehensive methodology to interrogate the concomitant changes to several aspects of dendritic spine structure and function as plasticity occurs has not been established. In this study, such a methodology was developed in order to facilitate future study of how a dendritic spine’s diffusional neck resistance, head volume, calcium-sensitive channels (on the postsynaptic density), and excitatory postsynaptic potential amplitude change concurrently as the spine undergoes activity-dependent regulation. This activity-dependent regulation also occurs in groups of spines called “clusters” <em>in vivo</em>, and the structural and functional dynamics of spines as these groups are formed also remains unknown. In order to to facilitate future <em>in vivo</em> studies on how clustered dendritic spines may change dynamically in both structure and function, a methodology for surgically accessing and recording calcium-based activity from the primary auditory cortex was developed, as the frequency-specific tuning of dendritic spines in this cortical area forms a compelling environment in which to study the relationship between spine form and function. </p>

Voltage-gated calcium (Cav) channels are a prerequisite for signal transmission at the first olfactory sensory neuron (OSN) synapse within the glomeruli of the main olfactory bulb (MOB). We showed previously that the N-type Cav channel subunit Cav2.2 is present in the vast majority of glomeruli and plays a central role in presynaptic transmitter release. Here, we identify a distinct subset of glomeruli in the MOB of adult mice that is characterized by expression of the P/Q-type channel subunit Cav2.1. Immunolocalization shows that Cav2.1+ glomeruli reside predominantly in the medial and dorsal MOB, and in the vicinity of the necklace glomerular region close to the accessory olfactory bulb. Few glomeruli are detected on the ventral and lateral MOB. Cav2.1 labeling in glomeruli colocalizes with the presynaptic marker vGlut2 in the axon terminals of OSNs. Electron microscopy shows that Cav2.1+ presynaptic boutons establish characteristic asymmetrical synapses with the dendrites of second-order neurons in the glomerular neuropil. Cav2.1+ glomeruli receive axonal input from OSNs that express molecules of canonical OSNs: olfactory marker protein, the ion channel Cnga2, and the phosphodiesterase Pde4a. In the main olfactory epithelium, Cav2.1 labels a distinct subpopulation of OSNs whose distribution mirrors the topography of the MOB glomeruli, that shows the same molecular signature, and is already present at birth. Together, these experiments identify a unique Cav2.1+ multiglomerular domain in the MOB that may form a previously unrecognized olfactory subsystem distinct from other groups of necklace glomeruli that rely on cGMP signaling mechanisms.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第20080号 / 医博第4173号 / 新制||医||1018(附属図書館) / 33196 / 京都大学大学院医学研究科医学専攻 / (主査)教授 長船 健二, 教授 川口 義弥, 教授 小川 修 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

No description available.

No description available.

Glutamate excitotoxicity is the predominant mechanism implicated in neuronal cell death associated with neurological disorders such as stroke, epilepsy, traumatic brain injury and ALS. Excessive stimulation of NMDA subtypes of glutamate receptors leads to protracted intracellular calcium elevations triggering calcium mediated neurotoxic mechanisms culminating in delayed neuronal cell death. In addition, glutamate excitotoxicity induces a NMDA dependent extended neuronal depolarization mediated by continuous calcium influx that correlates with delayed neuronal death. Attempts to prevent neuronal death by blocking calcium entry into the neurons using calcium channel blockers or NMDA receptor antagonists have failed to provide any beneficial effects in clinical trials. Thus, calcium continues to enter the neurons despite the presence of calcium entry blockers. This phenomenon is known as the "calcium paradox of stroke" and represents a major problem in developing effective therapies for treatment of stroke. Here employing a combination of patch clamp recordings, fluorescent calcium imaging and neuronal cell death assays in well-characterized in vivo and in vitro models of glutamate excitotoxicity, we report the discovery of a novel calcium permeable ion channel that is activated by excitotoxic glutamate injury and mediates a calcium current that is an early initiating step in causing neuronal death. Blocking this calcium permeable channel with high concentrations of Zn2+ or Gd3+ by removing extracellular calcium for a significant time period after the initial injury is effective in preventing calcium entry, apoptosis and neuronal death, thus accounting for the calcium paradox. This injury induced-calcium permeable channel provides a unique mechanism for calcium entry following stroke and offers a new target for extending the therapeutic window for preventing neuronal death after the initial excitotoxic (stroke) injury.

Dans le diabète de type 2 établi, l'hyperglycémie chronique, un taux élevé d'acides gras libres et l'inflammation induisent un stress oxydatif (SO) au niveau de la cellule beta. Le SO, qui apparaît dès le stade de pré-diabète, peut induire un dysfonctionnement précoce de cette cellule. Ainsi, la protection de la cellule β par des molécules anti-oxydantes pourrait ralentir la progression du pré-diabète au diabète.La quercétine, un flavonoïde, a présenté des propriétés antidiabétiques dans plusieurs études in vivo. Cependant, très peu de données traitent de son mécanisme d'action directement au niveau de la cellule beta. Dans ce contexte, nous avons étudié les effets de la quercétine au niveau de la cellule beta dans des conditions physiologiques et des conditions de SO.Nos résultats montrent qu'en présence de concentrations stimulantes de sécrétagogue, la quercétine potentialise la sécrétion d'insuline par un mécanisme impliquant l'augmentation de calcium intracellulaire et la potentialisation de ERK1/2 via l'activation des voies de la PKA et de la CaMK II. De plus, la quercétine protège la cellule beta du SO en sur-activant ERK1/2. Le resvératrol et la NAC, deux antioxydants de référence, sont inactifs dans ces conditions expérimentales.En absence de concentrations stimulantes de sécrétagogue, la quercétine induit une sécrétion d'insuline modérée en augmentant le calcium intracellulaire suite à une activation directe des CaV de type L. Dans ces conditions, l'activation de ERK1/2 induite par la quercétine, qui est indépendante de l'activation des voies de la PKA et de la CaMK II, ne serait pas impliquée dans le mécanisme sécrétoire. Nos résultats indiquent que le mécanisme d'action de la quercétine au niveau de la cellule β ne repose pas uniquement sur ses capacités anti-oxydantes mais fait intervenir des cibles pharmacologiques et la régulation de voies de signalisation intracellulaires. / In type 2 diabetes, chronic hyperglycaemia, elevated free fatty acids and inflammation induce oxidative stress (OS) in pancreatic β cell. SO, which appears at the stage of pre-diabetes, may induce early dysfunction of this cell. Thus, the β cell protection by antioxidant molecules could slow the progression of pre-diabetes to diabetes.Quercetin, a flavonoid, has shown antidiabetic properties in several in vivo studies. However, very few data address its mechanism of action directly at the β cell. In this context, we studied the effects of quercetin at the β cell under physiological conditions and conditions of OS.Our results show that in the presence of stimulating concentrations of secretagogue, quercetin potentiates insulin secretion by a mechanism involving increased intracellular calcium and potentiation of ERK1 / 2 via activation of the PKA and the CaMK II pathways. In addition, quercetin protects beta cell from OS via a suractivation of ERK1/2. Resveratrol and NAC, two antioxidants of reference are inactive under these experimental conditions.In the absence of stimulating concentration of secretagogue, quercetin induced moderate insulin secretion by increasing the intracellular calcium via a direct activation of L-type CaV Under these conditions, the activation of ERK1/2 induced by quercetin, which is independent of the activation pathways of PKA and CaMK II to, would not be involved in the secretory mechanism.Our results indicate that the mechanism of action of quercetin at the β cell not only based on its antioxidant capacity but involves pharmacological targets and the regulation of intracellular signaling pathways.

Le traitement et la gestion de la douleur sont depuis toujours une priorité pour le corps médical. Malgré leur importance pour la qualité de vie, les analgésiques couramment utilisés possèdent un ratio bénéfice/risque faible. La recherche de nouveaux concepts thérapeutiques pour lutter contre la douleur est donc une priorité. Afin de répondre à ce besoin, il faut d'abord comprendre les mécanismes de la perception de la douleur ainsi que, plus globalement, ceux permettant de percevoir son environnement. Dans ce contexte, de nombreuses études ont mis en évidence l'implication du canal calcique à bas seuil Cav3.2 dans les voies de la transmission de l'information douloureuse. Il représente donc une cible de choix pour le traitement de la douleur mais l'identité des neurones exprimant ces canaux ainsi que la fonction de Cav3.2 dans la physiologie des neurones sensoriels étaient jusqu'à présent inconnues. Au cours de cette thèse nous avons dans un premier temps décrit un nouvel inhibiteur des canaux calciques à bas seuil : le TTA-A2. Nous avons ainsi démontré que le TTA-A2 est un inhibiteur spécifique des canaux Cav3.1, Cav3.2, et Cav3.3. Il permet de diminuer l'excitabilité des neurones sensoriels exprimant Cav3.2, ce qui provoque une analgésie sur des animaux sains et pathologiques. Dans un deuxième temps nous nous sommes servis de ce nouvel outil en parallèle d'un nouveau modèle murin possédant une étiquette fluorescente (Knock in GFP) sur le canal Cav3.2 pour explorer la localisation et la fonction de Cav3.2 dans les neurones sensoriels. Nous avons ainsi découvert que Cav3.2 est exprimé dans des mécanorécepteurs à bas seuil impliqués dans la perception des stimuli mécaniques et thermiques nocifs ou non-nocifs. Le canal en lui-même se trouve aux endroits clés de la genèse et de la propagation du message nerveux périphérique, et module le seuil et la vitesse de conduction des potentiels d'action. Replacé dans le contexte de la bibliographie, l'ensemble de nos résultats montre que Cav3.2 permet de donner la modalité à bas seuil aux neurones l'exprimant. / Pain management and treatment have always been a priority for life quality. Despite this fact, analgesics commonly used present a bad benefice/risk ratio. Discovery of new therapeutic concepts to fight pain is highly required. To complete this task, we first need to better understand pain perception mechanisms, and more globally, mechanisms involved in the perception of our environment. In this context, numerous studies have shown that low threshold calcium channels Cav3.2 are involved in pain information transmission. Thus, it represents a good target for the treatment of pain. However, neuronal identity of Cav3.2-expressing sensory neurons and Cav3.2 functions in neuronal physiology are unknown. During this PhD we first described a new low voltage activated channel antagonist named TTA-A2. We demonstrated that TTA-A2 is a powerful nanomolar specific agonist of Cav3.1, Cav3.2 and Cav3.3. This molecule is able to reduce excitability in sensory neurons expressing Cav3.2, and is able to generate a strong analgesic effect on naive and pathologic animals. In the other part of this PhD, we used this new tool combined to a new transgenic mouse that expressed Cav3.2 tagged with a fluorescent protein (Knock-in GFP). With these new tools we discovered that Cav3.2 is expressed in low threshold mechanoreceptors involved in detection of painful and non painful mechanical and thermal stimuli. Cav3.2 itself is expressed at key localisations that allow action potential generation and propagation, and modulate threshold and speed conduction of action potential. Taken together, these results show that Cav3.2 gives the “low threshold” modality to neurons.